Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139721 · ClinicalTrials.gov registry record
Medtronic HAMMOCK Post Approval Study
A clinical trial of Heart Valve Diseases, sponsored by Medtronic Cardiac Surgery.
- Completed
- Registry status
- 122
- Enrollment target
- 7
- Study locations
NCT03139721: Completed study of Heart Valve Diseases, sponsored by Medtronic Cardiac Surgery.
NCT03139721 is a study of Heart Valve Diseases that has completed, run by Medtronic Cardiac Surgery. The registered enrollment target is 122 participants, below the 1,075-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (89% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03139721, a study of Heart Valve Diseases, has completed, sponsored by Medtronic Cardiac Surgery.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is being conducted to satisfy the post-CE approval requirement.
Primary Outcome
Number of deaths, reinterventions, or explants related to the valve
Conditions Studied
Interventions
- DEVICE Mosaic model 305, model 310, and ultra model 305
Study Locations (7)
Other
- Universitätsklinikum Hamburg-Eppendorf - Hamburg
- Deutsches Herzzentrum München Klinik an der TU München - München
- Institute of Cardiology in Warsaw - Warsaw
Indiana
- Franciscan Saint Francis Health - Indianapolis
Ohio
- ProMedica Toledo Hospital - Toledo
Washington
- Saint Joseph Medical Center - Tacoma
Wisconsin
- Bellin Memorial Hospital - Green Bay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2017-06-19 |
| Est. Completion | 2021-06-21 |
What the finished NCT03139721 record still lists
NCT03139721 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,075-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Heart Valve Diseases appearing as the primary indexed condition, and to 1 intervention - of which Mosaic model 305, model 310, and ultra model 305 is the first listed.
NCT03139721 lists 7 locations in 5 states (Other, Indiana, Ohio).
Frequently Asked Questions
What is clinical trial NCT03139721 about?
NCT03139721 is a clinical study titled "Medtronic HAMMOCK Post Approval Study". This study is being conducted to satisfy the post-CE approval requirement.
What is the current status of trial NCT03139721?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2017-06-19. Estimated completion is 2021-06-21.
What conditions does trial NCT03139721 study?
This clinical trial studies the following conditions: Heart Valve Diseases.
What interventions are being tested in trial NCT03139721?
The interventions under investigation include: Mosaic model 305, model 310, and ultra model 305 (DEVICE).
Who is sponsoring clinical trial NCT03139721?
This trial is sponsored by Medtronic Cardiac Surgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03139721 being conducted?
This trial has 7 study locations across Indiana, Ohio, Washington, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Valve Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03139721's enrollment target sits among peer trials
122 9th of 13 higher than 5 of 13 other Heart Valve Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Valve Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
The TRICURE EFS Study
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
Transpacific TAVR Registry
RECRUITING
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI